Organoids in translation: a bench-to-bedside framework for pancreatic cancer precision medicine
Abstract Introduction Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies with a 5-year survival rate of < 13%. Standard treatments such as FOLFIRINOX or gemcitabine/nab-paclitaxel yield modest response rates, underscoring the urgent need for precision oncology approaches....
Sparad:
| Huvudupphov: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMC
2026-01-01
|
| Serie: | Journal of Translational Medicine |
| Ämnen: | |
| Länkar: | https://doi.org/10.1186/s12967-025-07596-8 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|